Skip to main content

Table 1 Demographics of very elderly (≥80 years old) lung cancer patients

From: Real-world treatment patterns for patients 80 years and older with early lung cancer: a nationwide claims study

Characteristic

Treatment, No. (%)

Total

(N = 1,684)

Surgery

(N = 1,262)

SBRT

(N = 422)

Mean age, years

82.3 ± 2.5

82.0 ± 2.2

83.2 ± 3.1

Sex

 Male

1,207 (71.7)

904 (71.6)

303 (71.8)

 Female

477 (28.3)

358 (28.4)

119 (28.2)

Chemotherapya

 No

1,540 (91.4)

1,152 (91.3)

388 (91.9)

 Yes

144 (8.6)

110 (8.7)

34 (8.1)

Year of treatment

 2008

64

58 (90.6)

6 (9.4)

 2009

83

72 (86.7)

11 (13.3)

 2010

105

89 (84.8)

16 (15.2)

 2011

111

90 (81.1)

21 (18.9)

 2012

186

139 (74.7)

47 (25.3)

 2013

219

154 (70.3)

65 (29.7)

 2014

255

188 (73.7)

67 (26.3)

 2015

297

212 (71.4)

85 (28.6)

 2016

364

260 (71.4)

104 (28.6)

Follow-up, months

 Median

19.4

20.4

16.8

 IQR

7.2–36.5

7.4–40.3

6.8–30.0

Median OS, months

 Median

49.8

56.4

35.5

 95% CI

44.7–56.3

49.1–66.5

28.9–41.7

30-day mortality

 No. (%)

36 (2.2)

30 (2.4)

6 (1.5)

 95% CI

1.5–2.9

1.6–3.3

0.3–2.6

  1. aDefined as patients who received any type of chemotherapy after 3 months of local treatment
  2. All values are presented as the number (%). N number, OS overall survival, CI confidence interval, SBRT stereotactic body radiation therapy